Nasdaq moves to delist Nexalin Technology (NASDAQ: NXL) shares
Rhea-AI Filing Summary
On July 24, 2026, Nexalin Technology, Inc. received a Nasdaq Staff Determination letter stating that its common stock is scheduled for delisting from The Nasdaq Capital Market after the company failed to regain compliance with the $1.00 minimum bid price requirement within a 180-day period ending July 20, 2026.
Nasdaq also found the company ineligible for a second 180-day compliance period because it does not meet the $5,000,000 minimum stockholders' equity initial listing standard. The securities are slated to be suspended on August 4, 2026 and a Form 25-NSE filed, but Nexalin has timely requested a hearing before a Nasdaq Hearings Panel, which stays the suspension pending a decision. The company states there can be no assurance the Panel will grant continued listing or that it will regain compliance with Nasdaq requirements.
Positive
- None.
Negative
- Nasdaq delisting risk: the company remains out of compliance with the $1.00 minimum bid price and $5,000,000 stockholders' equity standards, and its Nasdaq listing is scheduled for suspension on August 4, 2026 pending the outcome of an appeal.
8-K Event Classification
Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
1 item
Item 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Securities
The company received a delisting notice or transferred its listing to a different exchange.
Key Figures
Minimum bid price: $1.00 per share
Noncompliance period: 30 consecutive business days
Compliance period length: 180 calendar days
+3 more
6 metrics
Minimum bid price
$1.00 per share
Nasdaq Listing Rule 5550(a)(2) minimum bid price requirement for continued listing
Noncompliance period
30 consecutive business days
Period during which the bid price closed below $1.00 per share
Compliance period length
180 calendar days
Initial grace period to regain minimum bid price compliance ending July 20, 2026
Minimum stockholders' equity
$5,000,000
Nasdaq initial listing stockholders' equity requirement not currently met
Scheduled suspension date
August 4, 2026
Date securities are scheduled for suspension from The Nasdaq Capital Market
Appeal deadline
July 31, 2026, 4:00 p.m. Eastern Time
Deadline to submit a hearing request to the Nasdaq Hearings Panel
Key Terms
Minimum Bid Price Requirement, Form 25-NSE, Nasdaq Hearings Panel, reverse stock split, +1 more
5 terms
Minimum Bid Price Requirement regulatory
"did not comply with Nasdaq Listing Rule 5550(a)(2), the Minimum Bid Price Requirement"
A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.
Form 25-NSE regulatory
"a Form 25-NSE will be filed with the Securities and Exchange Commission"
Form 25‑NSE is an official filing used to notify the stock exchange that a company’s securities are being removed from trading on that exchange, similar to handing in a key when a shop closes. Investors care because removal ends public trading on that venue, often cutting liquidity and making it harder to buy or sell shares, which can affect a stock’s price and how quickly investors can access cash or exit positions.
Nasdaq Hearings Panel regulatory
"The Company may appeal Nasdaq's determination to a Nasdaq Hearings Panel"
A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.
reverse stock split financial
"plan to regain compliance may include a commitment to effect a reverse stock split"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
Emerging Growth Company regulatory
"Emerging Growth Company under Rule 12b-2 of the Exchange Act"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What Nasdaq action did Nexalin Technology (NXL) report?
Nexalin Technology reported receiving a Nasdaq Staff Determination letter to delist its common stock from The Nasdaq Capital Market. The action follows noncompliance with the $1.00 minimum bid price rule and failure to qualify for an additional 180-day cure period.
Why is Nexalin Technology (NXL) facing potential delisting from Nasdaq?
The company did not regain compliance with Nasdaq's $1.00 minimum bid price requirement over 180 days and does not meet the $5,000,000 minimum stockholders' equity initial listing standard, making it ineligible for a second compliance period.
Has Nexalin Technology (NXL) appealed Nasdaq's delisting determination?
Yes. Nexalin Technology has timely requested a hearing before a Nasdaq Hearings Panel, which stays both the trading suspension and Form 25-NSE filing. The company must present a compliance plan, potentially including a reverse stock split, but there is no assurance of a favorable outcome.
What deadlines apply to Nexalin Technology (NXL) in the Nasdaq process?
The initial 180-day period to regain the $1.00 bid price compliance ended on July 20, 2026. Any hearing request must be submitted by July 31, 2026 at 4:00 p.m. Eastern Time, and trading suspension is scheduled for August 4, 2026 absent the hearing stay.